7 November 2018 - Deborah Wilkes
Archived
The Dutch Medicines Evaluation Board (MEB) has banned OTC sales of Mylan's Inhibin (hydroquinine hydrobromide) following concerns about cardiovascular safety.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.